Yahoo Finance Insider Sale: EVP Thomas Arnst Sells 8,148 Shares of Tenet Healthcare Corp (THC)
On May 1, 2024, Thomas Arnst, Executive Vice President, Chief Administrative Officer, and General Counsel of Tenet Healthcare Corp (NYSE:THC), sold 8,148 shares of the company. The transaction was documented in a recent SEC Filing. Following this transaction, over the past year, the insider has sold a total of 46,326 shares and has not made any purchases.
Tenet Healthcare Corp operates as a diversified healthcare services company that runs facilities including surgical hospitals, ambulatory surgery centers, and related outpatient services. The company's primary focus is on providing quality healthcare services.
The shares were sold at a price of $116.1, valuing the transaction at approximately $946,876.8. This sale occurred at a time when the stock has a market cap of approximately $11.75 billion and a price-earnings ratio of 4.67, which is significantly lower than the industry median of 24.89.
According to the GF Value, the intrinsic value of the stock is estimated at $80.40, making the current price-to-GF-Value ratio 1.44. This suggests that Tenet Healthcare Corp is significantly overvalued at the current price.
The insider transaction history for Tenet Healthcare Corp shows a trend of more sales than purchases among insiders over the past year, with 9 insider sales and no insider buys.
This recent sale by Thomas Arnst continues the trend of insider sales at Tenet Healthcare Corp, providing investors with insights into the internal sentiment towards the stock's current valuation.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
